Exchange: NASDAQ·Updated 04:10 PM EDT
LFCR logo

LFCRLifecore Biomedical Inc

$5.54
$0.02
(0.36%)
Today
Closed $5.54
$0.00
(0.00%)
After Hours
EarningsAug 5
Mkt Cap$207.8M
Vol229,682.00
News
all
press releases
Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS
Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.19). Lifecore Biomedical had a negative return on equity of 1,211.09% and a negative net margin of...
MarketBeat
News Placeholder
More News
News Placeholder
Lifecore Biomedical Q1 Earnings Call Highlights
Lifecore Biomedical (NASDAQ:LFCR) executives highlighted new commercial site transfer wins, continued cost reductions, and improving liquidity during the company's first-quarter 2026 earnings call...
MarketBeat
News Placeholder
Lifecore Biomedical Q1 2026 Earnings Call Transcript
read more...
Benzinga
News Placeholder
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Average Recommendation of "Hold" by Brokerages
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) has been assigned a consensus recommendation of 'Hold' from the five brokerages that are currently covering the company, Marketbeat.com...
MarketBeat
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $6.00
Barrington Research upped their target price on Lifecore Biomedical from $5.50 to $6.00 and gave the stock an "outperform" rating in a research note on Wednesday...
MarketBeat
News Placeholder
Lifecore Biomedical (LFCR) to Release Earnings on Tuesday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat
News Placeholder
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Receives Average Recommendation of "Hold" from Analysts
Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat
News Placeholder
Lifecore Biomedical (LFCR) to Release Earnings on Thursday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Thursday, April 2. (View Earnings Report at...
MarketBeat
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research
Barrington Research reiterated an "outperform" rating and issued a $5.50 price target on shares of Lifecore Biomedical in a research report on Tuesday...
MarketBeat
News Placeholder
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029
Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a standalone CDMO after divesting its former food...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.